Association of erythropoietin gene rs576236 polymorphism and risk of adrenal tumors in a Chinese population

Journal of Biomedical Research

Volumn 28, Issue 6, 2014, Pages 456-461

  Zhang, Chao ^a   Li, Zhongxing ^b   Cao, Qiang ^a   Qin, Chao ^a   Cai, Hongzhou ^a   Zhou, Hai ^a   Qian, Jian ^a   Tao, Liangjun ^a   Ju, Xiaobing ^a   Yin, Changjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Second People's Hospital of Zhenjiang   (China)

Author keywords

Adrenal tumor; Erythropoietin; Genetic susceptibility; Polymorphism

Indexed keywords

ERYTHROPOIETIN;

ADRENAL TUMOR; ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84928807444     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20130126     Document Type: Article

References (30)

1. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994;21:315-8.
2. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005;51:386-94.
3. Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol 2000;163:398-407.
4. Liu Y, Wang C, Ding ZY, Chen HJ, Ran XW, Huang H. Prognosis of patients with adrenocortical carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2012;43:293-6.
5. Maiese K, Li F, Chong ZZ. Erythropoietin in the brain: Can the promise to protect be fulfilled? Trends Pharmacol Sci 2004;25:577-83.
6. Caprara C, Grimm C. From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 2012;31:89-119.
7. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005;293:90-5.
8. Sasaki R, Masuda S, Nagao M. Erythropoietin: Multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 2000;64:1775-93.
9. Yasuda Y, Hara S, Hirohata T, Koike E, Yamasaki H, Okumoto K, et al. Erythropoietin-responsive sites in normal and malignant human lung tissues. Anat Sci Int 2010;85:204-13.
10. Golfam M, Samant R, Eapen L, Malone S. Effects of radiation and total androgen blockade on serum hemoglobin, testosterone, and erythropoietin in patients with localized prostate cancer. Curr Oncol 2012;19:e258-63.
11. Han ZG, Yu TT, Shan L. [expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density]. Zhonghua Zhong Liu Za Zhi 2012;34:605-8.
12. Lin YT, Chuang HC, Chen CH, Armas GL, Chen HK, Fang FM, et al. Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma. BMC Cancer 2012;12:194.
13. Zhang C, Duan X, Xu L, Ye J, Zhao J, Liu Y. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in her2-positive breast cancer cells. Breast Cancer Res Treat 2012;136:739-48.
14. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, Tazaki A, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003;24:1021-9.
15. Giatromanolaki A, Fiska A, Pitsiava D, Kartalis G, Koukourakis MI, Sivridis E. Erythropoietin receptors in endometrial carcinoma as related to hif1{alpha} and vegf expression. In Vivo 2009;23:699-703.
16. Kuster O, Simon P, Mittelbronn M, Tabatabai G, Hermann C, Strik H, et al. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence. Neuropathol Appl Neurobiol 2009;35:555-65.
17. Sinclair AM, Rogers N, Busse L, Archibeque I, Brown W, Kassner PD, et al. Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. Br J Cancer 2008;98:1059-67.
18. Papworth K, Bergh A, Grankvist K, Ljungberg B, Rasmuson T. Expression of erythropoietin and its receptor in human renal cell carcinoma. Tumour Biol 2009;30:86-92.
19. Wu P, Zhang N, Wang X, Zhang C, Li T, Ning X, et al. The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells. PLoS One 2012;7:e45122.
20. Percy MJ, McMullin MF, Lappin TR. Sequence analysis of the 39 hypoxia-responsive element of the human erythropoietin gene in patients with erythrocytosis. Biochem Mol Med 1997;62:132-4.
21. Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY. Polymorphisms in two genes, il-1b and ace, are associated with erythropoietin resistance in korean patients on maintenance hemodialysis. Exp Mol Med 2008;40:161-6.
22. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, et al. Brain capillary endothelial cells express two forms of erythropoietin receptor mrna. Eur J Biochem 1996;239:494-500.
23. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 1990;87:5978-82.
24. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular o2 tension. Proc Natl Acad Sci U S A 1995;92:5510-4.
25. Ratcliffe PJ. Understanding hypoxia signalling in cells-a new therapeutic opportunity? Clin Med 2006;6:573-8.
26. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD, et al. Mitochondrial complex iii is required for hypoxia-induced ros production and cellular oxygen sensing. Cell Metab 2005;1:401-8.
27. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic hif-alpha activation. Cell Metab 2005;1:393-9.
28. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, et al. Oxygen sensing requires mitochondrial ros but not oxidative phosphorylation. Cell Metab 2005;1:409-14.
29. Theodoropoulos GE, Gazouli M, Vaiopoulou A, Leandrou M, Nikouli S, Vassou E, et al. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis 2011;26:1113-8.
30. Putra AC, Tanimoto K, Arifin M, Hiyama K. Hypoxiainducible factor-1alpha polymorphisms are associated with genetic aberrations in lung cancer. Respirology 2011;16:796-802.